264
Views
0
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for perennial allergic rhinitis

&
Pages 543-553 | Published online: 28 Nov 2012

Bibliography

  • Bousquet J. editor. Allergic rhinitis and its impact on asthma (ARIA) update 2008. Allergy 2008;63(Suppl 88):1-33
  • Bjorksten B, Brunekreef B, Cookson WO, Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods. Eur Respir J 2004;24:406-12
  • Meltzer EO. Quality of life in adults and children with allergic rhinitis. J Allergy Clin Immunol 2001;108(1 Suppl):S45-53
  • Cazzavillan A, Castelnuovo P, Berlucchi M, Management of chronic rhinosinusitis in children. Pediatr Allergy Immunol 2012; In press
  • Schoenwetter WF, Dupclay L Jr, Appajosyula S, Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin 2004;20:305-17
  • Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol 2011;106(2 Suppl):S12-16
  • Cruz AA, Popov T, Pawankar R, Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA(2)LEN. Allergy 2007;62(Suppl 84):1-41
  • Shaaban R, Zureik M, Soussan D, Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372(9643):1049-57
  • Bousquet J, Gaugris S, Kocevar VS, Increased risk of asthma attacks and emergency visits among asthma patients with allergic rhinitis: a subgroup analysis of the improving asthma control trial. Clin Exp Allergy 2005;35:723-7
  • Greiner AN, Hellings PW, Rotiroti G, Scadding GK. Allergic rhinitis. Lancet 2011;378(9809):2112-22
  • Pawankar R, Yamagishi S, Takizawa R, Yagi T. Mast cell-IgE-and mast cell-structural cell interactions in allergic airway disease. Curr Drug Targets Inflamm Allergy 2003;2:303-12
  • Romagnani S. Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders? Allergy 2006;61:3-14
  • Dykewicz MS, Hamilos DL. Rhinitis and sinusitis. J Allergy Clin Immunol 2010;125(2 Suppl 2):S103-15
  • Schmetterer KG, Neunkirchner A, Pickl WF. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. FASEB J 2012;26(6):2253-76
  • Ciprandi G, Buscaglia S, Pesce GP, Minimal persistent inflammation is present at mucosal level in asymptomatic rhinitic patients with allergy due to mites. J Allergy Clin Immunol 1995;96:971-9
  • Ciprandi G, Vizzaccaro A, Cirillo I, Nasal eosinophils display the best correlation with symptoms, pulmonary function and inflammation in allergic rhinitis. Int Arch Allergy Immunol 2005;136:266-72
  • Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 2005;60:350-3
  • Ciprandi G, Cirillo I, Vizzaccaro A, Seasonal and perennial allergic rhinitis: is this classification adherent to real life? Allergy 2005;60:882-7
  • van Cauwenberge P, Bachert C, Passalacqua G, Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy 2000;55:116-34
  • Bousquet J, Annesi-Maesano I, Carat F, Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy 2005;35:728-32
  • Passalacqua G, Ciprandi G, Canonica GW. United airways disease: therapeutic aspects. Thorax 2000;55(Suppl 2):s26-7
  • Bousquet PJ, Combescure C, Neukirch F, Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy 2007;62:367-72
  • Global Initiative for Asthma management. Version 2011 Available from: www.ginasthma.com [Last accessed June 2012]
  • Bousquet J, Bachert C, Canonica GW, Extended Global Allergy and Asthma European Network, World Allergy Organization and Allergic Rhinitis and its Impact on Asthma Study Group. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol 2009;124:428-33
  • Scurati S, Frati F, Passalacqua G, Compliance adherence issues related to sublingual immunotherapy as perceived by allergists. Patient Prefer Adherence 2010;4:141-5
  • Moscato G, Pala G, Boillat MA, EAACI position paper: prevention of work-related respiratory allergies among pre-apprentices or apprentices and young workers. Allergy 2011;66:1164-73
  • Custovic A, van Wjik G. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy 2005;60:1112-15
  • Nurmatov U, van Schayck CP, Hurwitz B, Sheikh A. House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review. Allergy 2012;67:158-65
  • Sheikh A, Hurwitz B, Nurmatov U, van Schayck CP. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev 2010(7):CD001563
  • Brozek JL, Bousquet J, Baena-Cagnani CE, Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010;126:466-76
  • Blaiss MS. Safety update regarding intranasal corticosteroids for the treatment of allergic rhinitis. Allergy Asthma Proc 2011;32:413-18
  • Kushnir NM. The role of decongestants, cromolyn, guafenesin, saline washes, capsaicin, leukotriene antagonists, and other treatments on rhinitis. Immunol Allergy Clin North Am 2011;31:601-17
  • Noon L. Prophylactic inoculation against hay fever. Lancet 1911;i:1572-3
  • Windom HH, Lockey RF. An update on the safety of specific immunotherapy. Curr Opin Allergy Clin Immunol 2008;8:571-6
  • Bousquet J, Lockey R, Malling HJ. editors. World Health Organization Position Paper. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Allergy 1998;53(Suppl 72):3-13
  • Cox L, Nelson H, Lockey R, Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol 2011;127(1 Suppl):S1-55
  • Bousquet PJ, Durham SR, Cox L, Sublingual immunotherapy: WAO Position Paper 2009. Canonica GW, editors. Allergy 2009;64(Suppl 91):3-45
  • Bousquet J, Anto JM, Demoly P, WHO Collaborating Center for Asthma and Rhinitis. Severe chronic allergic (and related) diseases: a uniform approach–a MeDALL–GA2LEN–ARIA position paper. Int Arch Allergy Immunol 2012;158(3):216-31
  • Gelardi M, Russo C, Fiorella ML, When allergic rhinitis is not only allergic. Am J Rhinol Allergy 2009;23:312-15
  • Rondón C, Campo P, Togias A, Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol 2012;129:1460-7
  • Scadding G, Hellings P, Alobid I, Diagnostic tools in rhinology EAACI position paper. Clin Transl Allergy 2011;1:2
  • Ciprandi G, Incorvaia C, Scurati S, Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey. Curr Med Res Opin 2011;27:1005-11
  • De Vos C, Mitchev K, Pinelli ME, Non-interventional study comparing treatment satisfaction in patients treated with antihistamines. Clin Drug Investig 2008;28:221-30
  • Thomas M, Yawn BP, Price D, European Position Paper on Rhinosinusitis and Nasal Polyps Group. EPOS primary care guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007 - a summary. Prim Care Respir J 2008;17:79-89
  • Ciprandi G. Clinical utility and patient adherence in the use of ebastine for allergic rhinitis. Patient Prefer Aherence 2010;14:389-5
  • Metz M, Maurer M. Rupatadine for the treatment of allergic rhinitis and urticaria. Expert Rev Clin Immunol 2011;1:15-20
  • Fantin S, Maspero J, Bisbal C, A 12-week placebo-controlled study of rupatadine 10 mg once daily compared with cetirizine 10 mg once daily, in the treatment of persistent allergic rhinitis. Allergy 2008;63:924-31
  • Carter NJ. Bilastine in allergic rhinitis and urticaria. Drugs 2012;72:1257-69
  • Sastre J, Mullol J, Valero A, Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo in the treatment of perennial allergic rhinitis. Curr Med Res Opin 2012;28:121-30
  • Durham SR. Effect of intranasal corticosteroid treatment on asthma in children and adults. Allergy 1999;54(Suppl 57):124-31
  • Dent G. Ciclesonide. Curr Opin Investig Drugs 2002;3(1):78-83
  • Schmidt BM, Timmer W, Georgens AC. The new topical steroid ciclesonide is effective in the treatment of allergic rhinitis. J Clin Pharmacol 1999;39:1062-9
  • Jacobs RL. Ciclesonide for the treatment of seasonal allergic rhinitis. Expert Rev Clin Immunol 2011;7:735-41
  • Mohar D, Berger WE, Laforce C, Efficacy and tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis. Allergy Asthma Proc 2012;33:19-26
  • Berger WE, Mohar DE, Laforce C, A 26-week tolerability study of ciclesonide nasal aerosol in patients with perennial allergic rhinitis. Am J Rhinol Allergy 2012;26:302-7
  • Ahlstrom-Emanuelsson C, Andersson M, Persson C, Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis. Clin Exp Allergy 2004;34:731-5
  • Schmidt BM, Kusma M, Feuring M, The phosphodiesterase 4 inhibitor roflumilast is effective in the treatment of allergic rhinitis. J Allergy Clin Immunol 2001;108:530-6
  • Erin EM, Leaker BR, Zacharasiewicz A, Effects of a reversible beta-tryptase and trypsin inhibitor (RWJ-58643) on nasal allergic responses. Clin Exp Allergy 2006;36:458-64
  • Guyer BJ, Shimamoto SR, Bradhurst AL. Mast cell inhibitor R112 is well tolerated and affects prostaglandin D2 but not other mediators, symptoms, or nasal volumes in a nasal challenge model of allergic rhinitis. Allergy Asthma Proc 2006;27:208-13
  • Rimmer J, Peake HL, Santos CM. Targeting adenosine receptors in the treatment of allergic rhinitis: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy 2007;37:8-14
  • Kiss R, Keserű GM. Histamine H4 receptor ligands and their potential therapeutic applications: an update. Expert Opin Ther Pat 2012;22:205-21
  • Daley-Yates P, Ambery C, Sweeney L, The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis. Int Arch Allergy Immunol 2012;158:84-98
  • Hampel FC, Ratner PH, Van Bavel J, Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol 2010;105:168-73
  • Meltzer EO, Laforce C, Ratner P, MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc 2012;33:324-32
  • Carr W, Bernstein J, Lieberman P, A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol 2012;129:1282-9
  • Chervinsky P, Casale T, Townley R, Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol 2003;91:160-7
  • Oba Y, Saltzman GA. Cost-effectiveness analysis of omalizumab in adults and adolescents with moderate-to-severe allergic asthma. J Allergy Clin Immunol 2004;114:265-9
  • Vignola AM, Humbert M, Bousquet J, Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709-17
  • Kon OM, Sihra BS, Compton CH, Randomised dose-ranging placebo controlled study of chimeric antibody to CD4 (keliximab) in chronic severe asthma. Lancet 1998;352:1109-13
  • Bryan SA, O'Connor BJ, Matti S, Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356:2149-53
  • Nair P, Pizzichini MM, Kjarsgaard M, Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985-93
  • Washio Y, Ohashi Y, Tanaka A, Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis. Acta Otolaryngol Suppl 1998;538:126-32
  • Furukido K, Takeno S, Ueda T, Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies. Am J Rhinol 2002;16:329-36
  • Shimizu S, Hattori R, Majima Y, Shimizu T. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats. Ann Otol Rhinol Laryngol 2009;118:67-72
  • Benson M, Mobini R, Barrenäs F, A haplotype in the inducible T-cell tyrosine kinase is a risk factor for seasonal allergic rhinitis. Allergy 2009;64:1286-91
  • Masuda ES, Schmitz J. Syk inhibitors as treatment for allergic rhinitis. Pulm Pharmacol Ther 2008;21:461-7
  • Meltzer EO, Berkowitz RB, Grossbard EB. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment. J Allergy Clin Immunol 2005;115:791-6
  • Jutel M, Akdis CA. Immunological mechanisms of allergen-specific immunotherapy. Allergy 2011;66:725-32
  • Möller C, Dreborg S, Ferdousi HA, Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 2002;109:251-6
  • Novembre E, Galli E, Landi F, Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004;114:851-7
  • Marogna M, Tomassetti D, Bernasconi A, Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 2008;101206-11
  • Cosmi L, Santarlasci V, Angeli R, Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 2006;261-72
  • Ciprandi G, Fenoglio D, Cirillo I, Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report. Ann Allergy Asthma Immunol 2005;95:38-44
  • Passalacqua G, Canonica GW. Sublingual immunotherapy in respiratory allergy: efficacy and safety. Immunol Allergy Clin North Am 2011;31:265-77
  • Casale TB, Stokes JR. Future forms of immunotherapy. J Allergy Clin Immunol 2011;127:8-15
  • Senti G, Prinz Vavricka BM. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci USA 2008;105:17908-12
  • Senti G, von Moos S, Kündig TM. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy? Allergy 2011;66:798-809
  • Drachenber KJ, Wheeler A, Stubner P, Horak F. A well tolerated grass pollen specific allergy vaccine containing a novel adjuvant MPL reduces allergy symptoms after only four preseasonal injections. Allergy 2001;56:498-505
  • Creticos PS, Eiden JJ, Broide DH, Immunotherapy with immunostimulatory oligonucleotides linked to purified Ragweed Amb a1 allergen: effects on antibody production, Nasal Allergen Provocation, and Ragweed Seasonal Rhinitis. J Allergy Clin Immunol 2002;109:743-4
  • Jutel M, Jaeger L, Suck R, Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol 2005;116:608-13
  • Pauli G, Larsen TH, Rak S, Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol 2008;122:951-60
  • Cromwell O, Häfner D, Nandy A. Recombinant allergens for specific immunotherapy. J Allergy Clin Immunol 2011;127:865-72
  • Food and Agriculture Organization, World Health Organization (FAO/WHO) Report of Joint FAO/WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. FAO/WHO Report no. 10-1-2001. WHO INT; Córdoba, Argentina
  • Kaur IP, Chopra K, Saini A. Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 2002;15:1-9
  • Wanke CA. Do probiotics prevent childhood illnesses? BMJ 2001;322:1318-19
  • Boyle RJ, Tang ML. The role of probiotics in the management of allergic disease. Clin Exp Allergy 2006;36:568-76
  • Kalliomaki M, Kirjavainen P, Eerola E, Distinct patterns of neonatal gut microflora in infants in whom atopy was and was not developing. J Allergy Clin Immunol 2001;107:129-34
  • Kallomaki M, Salminen S, Arvilommi H, Probiotics in primary prevention of atopic disease: a randomised placebo controlled trial. Lancet 2001;357:1076-9
  • Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Probiotics for the treatment of eczema: a systematic review. Clin Exp Allergy 2009;39:1117-27
  • Peng GC, Hsu CH. The efficacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr Allergy Immunol 2005;16:433-8
  • Ivory K, Chambers SJ, Pin C, Oral delivery of Lactobacillus casei Shirota modifies allergen-induced immune responses in allergic rhinitis. Clin Exp Allergy 2008;38:1282-9
  • Giovannini M, Agostoni C, Riva E, Felicita Study Group. A randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitis. Pediatr Res 2007;62:215-20
  • Ciprandi G, Vizzaccaro A, Cirillo I, Tosca MA. Bacillus clausii effects in children with allergic rhinitis. Allergy 2005;60:702-3
  • Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol 2008;101:570-9
  • Ozdemir O. Any benefits of probiotics in allergic disorders? Allergy Asthma Proc 2010;31:103-11
  • Cuppari C, Salpietro A, Grasso L, HMGB1 and allergic rhinitis in children: preliminary results after corticosteroids or glycyrrhetic acid intranasal treatment. Child 2012;2:8
  • Wjst M, Hyppönen E. Vitamin D serum levels and allergic rhinitis. Allergy 2007;62:1085-6
  • Akbar NA, Zacharek MA. Vitamin D: immunomodulation of asthma, allergic rhinitis, and chronic rhinosinusitis. Curr Opin Otolaryngol Head Neck Surg 2011;19:224-8
  • Passalacqua G, Bousquet PJ, Carlsen KH. ARIA update: I-systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol 2006;117:1054-62
  • Lee MS, Pittler MH, Shin BC, Acupuncture for allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol 2009;102:269-79
  • Brehmer D. Endonasal phototherapy with Rhinolight for the treatment of allergic rhinitis. Expert Rev Med Devices 2010;7:21-6

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.